Trial · NCT07903142
Comparison of High-Intensity and Conventional Physical Therapy in Musculoskeletal Disorders
NCT07903142, Not applicable, Not yet recruiting, BTL Industries Ltd.
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Comparison of High-Intensity and Conventional Physical Therapy in Musculoskeletal Disorders. Trials, record NCT07903142. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT07903142
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Comparison of High-Intensity and Conventional Physical Therapy in Musculoskeletal Disorders
- NCT number
- NCT07903142
- Status
- Not yet recruiting
- Phases
- Not applicable
- Enrollment
- 60 participants, estimated
- Lead sponsor
- BTL Industries Ltd.
- Conditions
Low Back Pain, Radicular Syndrome, Sacroiliac Joint Dysfunction, Shoulder Impingement Syndrome, Rotator Cuff Tendinopathy, Shoulder Osteoarthritis, Acromioclavicular Joint Osteoarthritis, Knee Osteoarthritis, Patellofemoral Pain Syndrom
- Interventions
Repetitive Peripheral Magnetic Stimulation (rPMS), High-Intensity Laser Therapy (HIL), Extracorporeal Shockwave Therapy (ESWT), Pulsed Electromagnetic Field Therapy (PEMF), Therapeutic Ultrasound (USN), Electrotherapy (Medium-Frequency Currents)
- First posted
- 2026-10-29
- Last updated
- 2026-10-29
Source ClinicalTrials.gov
Registered outcomes6
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Change in Pain Intensity (VAS) | Immediately before each treatment session (Sessions 1 through 5) and immediately following the 5th (final) treatment session (over a period of up to approximately 3 weeks) | Pain intensity assessed using the Visual Analogue Scale (0 = no pain, 10 = worst possible pain). |
| Secondary | Change in Patient-Specific Functional Scale (PSFS) | Baseline (Day 1) and at the completion of 5 treatment sessions (up to approximately 3 weeks). | Self-reported patient-specific functional status, 5 self-reported activities (0 = unable to perform, 10 = no limitation). |
| Secondary | Change in Range of Motion (ROM) | Baseline (Day 1) and at the completion of 5 treatment sessions (up to approximately 3 weeks). | Objective measurement of joint mobility using a goniometer. |
| Secondary | Change in Oswestry Disability Index (ODI) | Baseline (Day 1) and at the completion of 5 treatment sessions (up to approximately 3 weeks). | Specific functional evaluation for patients with Low Back Pain, 10 questions (0 = no limitations, 5 = unable to perform). |
| Secondary | Change in Shoulder Pain and Disability Index (SPADI) | Baseline (Day 1) and at the completion of 5 treatment sessions (up to approximately 3 weeks). | Specific functional evaluation for patients with shoulder disorders, 5 questions for pain assessment (0 = no pain, 10 = worst possible pain), 8 questions for activities (0 = no limitation, 10 = unable to perform). |
| Secondary | Change in Lower Extremity Functional Scale (LEFS) | Baseline (Day 1) and at the completion of 5 treatment sessions (up to approximately 3 weeks). | Specific functional evaluation for patients with knee disorders, 20 activities (0 = unable to perform, 4 = no limitation). |
Source ClinicalTrials.gov
Outcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT07903142
GET https://conductscience.org/api/trials/v1/NCT07903142/registered